| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 1.13e-08 | 11 | 50 | 4 | GO:0008503 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 1.04e-07 | 18 | 50 | 4 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.31e-07 | 19 | 50 | 4 | GO:0004890 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.56e-07 | 50 | 50 | 5 | GO:0099095 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 2.46e-07 | 22 | 50 | 4 | GO:0016917 | |
| GeneOntologyMolecularFunction | chloride channel activity | 2.40e-06 | 86 | 50 | 5 | GO:0005254 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 5.84e-06 | 103 | 50 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.25e-05 | 57 | 50 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.50e-05 | 125 | 50 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.53e-05 | 60 | 50 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | diazepam binding | 1.84e-05 | 3 | 50 | 2 | GO:0050809 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.10e-05 | 65 | 50 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.10e-05 | 65 | 50 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.88e-05 | 24 | 50 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.71e-05 | 75 | 50 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 3.73e-05 | 151 | 50 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 4.11e-05 | 77 | 50 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 6.74e-05 | 171 | 50 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | IL12B OR10AG1 OR9A4 P2RY13 TAS2R45 PTPRU ACVR2B TAS2R46 GABRA1 GABRA2 GABRA3 GABRA6 | 9.71e-05 | 1353 | 50 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.14e-04 | 100 | 50 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.19e-04 | 193 | 50 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.31e-04 | 197 | 50 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.45e-03 | 334 | 50 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 2.07e-03 | 27 | 50 | 2 | GO:0004683 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 2.07e-03 | 27 | 50 | 2 | GO:0033038 | |
| GeneOntologyMolecularFunction | taste receptor activity | 3.09e-03 | 33 | 50 | 2 | GO:0008527 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.69e-03 | 459 | 50 | 5 | GO:0005216 | |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 7.99e-07 | 30 | 50 | 4 | GO:1904862 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 1.51e-06 | 35 | 50 | 4 | GO:0007214 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 7.52e-06 | 112 | 50 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | chloride transport | 1.44e-05 | 128 | 50 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.80e-05 | 134 | 50 | 5 | GO:0098661 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 3.10e-05 | 74 | 50 | 4 | GO:0051932 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 3.40e-05 | 153 | 50 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 7.38e-05 | 180 | 50 | 5 | GO:0015698 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 7.98e-05 | 183 | 50 | 5 | GO:0006820 | |
| GeneOntologyBiologicalProcess | synapse organization | 2.22e-04 | 685 | 50 | 8 | GO:0050808 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.09e-07 | 19 | 50 | 4 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.68e-07 | 21 | 50 | 4 | GO:1902710 | |
| GeneOntologyCellularComponent | chloride channel complex | 2.43e-07 | 57 | 50 | 5 | GO:0034707 | |
| GeneOntologyCellularComponent | dendrite membrane | 9.70e-06 | 56 | 50 | 4 | GO:0032590 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 2.35e-05 | 503 | 50 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron projection membrane | 4.41e-05 | 82 | 50 | 4 | GO:0032589 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 5.58e-05 | 5 | 50 | 2 | GO:0005954 | |
| GeneOntologyCellularComponent | cell projection membrane | 7.01e-05 | 431 | 50 | 7 | GO:0031253 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.43e-04 | 210 | 50 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 5.54e-04 | 67 | 50 | 3 | GO:0098686 | |
| GeneOntologyCellularComponent | postsynapse | CAMK2B CAMK2G RAPGEF4 NBEA SNAP47 GABRA1 GABRA2 GABRA3 GABRA6 | 6.14e-04 | 1018 | 50 | 9 | GO:0098794 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 6.35e-04 | 164 | 50 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | dendrite | 9.06e-04 | 858 | 50 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 9.20e-04 | 860 | 50 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.04e-03 | 20 | 50 | 2 | GO:0042405 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.35e-03 | 201 | 50 | 4 | GO:0099634 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.05e-03 | 378 | 50 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | receptor complex | 2.53e-03 | 581 | 50 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.76e-03 | 405 | 50 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | presynaptic active zone | 4.67e-03 | 141 | 50 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 5.20e-03 | 45 | 50 | 2 | GO:0033017 | |
| MousePheno | abnormal GABA-mediated receptor currents | 1.85e-05 | 18 | 41 | 3 | MP:0004008 | |
| Domain | GABAAa_rcpt | 6.25e-10 | 6 | 49 | 4 | IPR001390 | |
| Domain | GABAA/Glycine_rcpt | 3.57e-07 | 23 | 49 | 4 | IPR006028 | |
| Domain | Neurotransmitter_ion_chnl_CS | 5.75e-06 | 45 | 49 | 4 | IPR018000 | |
| Domain | Neur_chan_memb | 6.29e-06 | 46 | 49 | 4 | PF02932 | |
| Domain | Neur_chan_LBD | 6.86e-06 | 47 | 49 | 4 | PF02931 | |
| Domain | Neur_channel | 6.86e-06 | 47 | 49 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 6.86e-06 | 47 | 49 | 4 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 6.86e-06 | 47 | 49 | 4 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 6.86e-06 | 47 | 49 | 4 | IPR006029 | |
| Domain | - | 6.86e-06 | 47 | 49 | 4 | 2.70.170.10 | |
| Domain | CaMKII_AD | 4.03e-05 | 4 | 49 | 2 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 4.03e-05 | 4 | 49 | 2 | IPR013543 | |
| Domain | - | 5.16e-04 | 13 | 49 | 2 | 3.10.450.50 | |
| Domain | NTF2-like_dom | 6.93e-04 | 15 | 49 | 2 | IPR032710 | |
| Domain | Glyco_trans_31 | 7.90e-04 | 16 | 49 | 2 | IPR002659 | |
| Domain | Galactosyl_T | 7.90e-04 | 16 | 49 | 2 | PF01762 | |
| Domain | BRCT | 1.12e-03 | 19 | 49 | 2 | PF00533 | |
| Domain | BRCT | 1.51e-03 | 22 | 49 | 2 | SM00292 | |
| Domain | - | 1.65e-03 | 23 | 49 | 2 | 3.40.50.10190 | |
| Domain | TAS2R | 2.11e-03 | 26 | 49 | 2 | PF05296 | |
| Domain | T2R | 2.11e-03 | 26 | 49 | 2 | IPR007960 | |
| Domain | BRCT | 2.11e-03 | 26 | 49 | 2 | PS50172 | |
| Domain | BRCT_dom | 2.44e-03 | 28 | 49 | 2 | IPR001357 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 6.24e-09 | 9 | 39 | 4 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 1.04e-08 | 10 | 39 | 4 | M477 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 7.29e-08 | 205 | 39 | 8 | M752 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.17e-07 | 144 | 39 | 7 | MM14501 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 6.00e-07 | 270 | 39 | 8 | M15514 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 6.07e-07 | 60 | 39 | 5 | M976 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 6.07e-07 | 60 | 39 | 5 | MM15708 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 1.49e-06 | 31 | 39 | 4 | M39369 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.56e-06 | 211 | 39 | 7 | MM14502 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 2.32e-06 | 10 | 39 | 3 | MM1401 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 3.09e-06 | 37 | 39 | 4 | M749 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 3.45e-06 | 38 | 39 | 4 | M39854 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 4.71e-06 | 41 | 39 | 4 | M512 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.36e-05 | 411 | 39 | 8 | M735 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.43e-05 | 54 | 39 | 4 | M26911 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 3.21e-05 | 335 | 39 | 7 | MM14503 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.08e-04 | 90 | 39 | 4 | M6467 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 2.04e-04 | 314 | 39 | 6 | M600 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE | 2.07e-04 | 8 | 39 | 2 | M10546 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.40e-04 | 44 | 39 | 3 | M27934 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 3.16e-04 | 119 | 39 | 4 | M48309 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 3.31e-04 | 10 | 39 | 2 | M26910 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 3.94e-04 | 52 | 39 | 3 | M5785 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 6.65e-04 | 14 | 39 | 2 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 6.65e-04 | 14 | 39 | 2 | M47388 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 7.65e-04 | 15 | 39 | 2 | M47385 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 8.68e-04 | 272 | 39 | 5 | M13380 | |
| Pathway | WP_SEROTONIN_AND_ANXIETY | 9.88e-04 | 17 | 39 | 2 | M39511 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 9.88e-04 | 17 | 39 | 2 | M47387 | |
| Pathway | WP_SEROTONIN_AND_ANXIETY | 9.88e-04 | 17 | 39 | 2 | MM15861 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 1.24e-03 | 19 | 39 | 2 | M47957 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 1.24e-03 | 19 | 39 | 2 | MM15473 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 1.37e-03 | 20 | 39 | 2 | M17670 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.37e-03 | 20 | 39 | 2 | M759 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.52e-03 | 21 | 39 | 2 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 1.52e-03 | 21 | 39 | 2 | M27944 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.66e-03 | 22 | 39 | 2 | MM15104 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.82e-03 | 23 | 39 | 2 | MM14953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.82e-03 | 23 | 39 | 2 | M47512 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 1.82e-03 | 23 | 39 | 2 | M27949 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.98e-03 | 24 | 39 | 2 | M47509 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.07e-03 | 92 | 39 | 3 | MM14951 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.15e-03 | 25 | 39 | 2 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.15e-03 | 25 | 39 | 2 | M47511 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.21e-03 | 94 | 39 | 3 | M2843 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 2.32e-03 | 26 | 39 | 2 | M39711 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.69e-03 | 28 | 39 | 2 | M47508 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 2.69e-03 | 28 | 39 | 2 | M837 | |
| Pathway | KEGG_MELANOGENESIS | 2.71e-03 | 101 | 39 | 3 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.71e-03 | 101 | 39 | 3 | M1979 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.89e-03 | 29 | 39 | 2 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 3.30e-03 | 31 | 39 | 2 | M7223 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 3.30e-03 | 31 | 39 | 2 | MM15691 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.51e-03 | 32 | 39 | 2 | M27455 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 3.51e-03 | 32 | 39 | 2 | M27900 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 3.72e-03 | 113 | 39 | 3 | M16817 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 3.73e-03 | 33 | 39 | 2 | M39875 | |
| Pathway | REACTOME_RAF_ACTIVATION | 3.96e-03 | 34 | 39 | 2 | M27556 | |
| Pathway | REACTOME_RAF_ACTIVATION | 4.19e-03 | 35 | 39 | 2 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 4.19e-03 | 35 | 39 | 2 | MM15109 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 4.67e-03 | 37 | 39 | 2 | MM15067 | |
| Pubmed | 5.66e-11 | 6 | 50 | 4 | 20457185 | ||
| Pubmed | 1.32e-10 | 7 | 50 | 4 | 16101898 | ||
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 8175718 | ||
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 11528422 | ||
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 1.24e-09 | 11 | 50 | 4 | 9924185 | |
| Pubmed | 2.68e-09 | 13 | 50 | 4 | 22569571 | ||
| Pubmed | 2.68e-09 | 13 | 50 | 4 | 22640814 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 16835366 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 15304513 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 1356407 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 15017002 | ||
| Pubmed | Association study between GABA receptor genes and anxiety spectrum disorders. | 1.12e-08 | 4 | 50 | 3 | 19842164 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 25865415 | ||
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 25080596 | ||
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 26518133 | ||
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 1.12e-08 | 4 | 50 | 3 | 18821008 | |
| Pubmed | 1.14e-08 | 18 | 50 | 4 | 19078961 | ||
| Pubmed | 2.22e-08 | 21 | 50 | 4 | 25708312 | ||
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 2.79e-08 | 5 | 50 | 3 | 30104684 | |
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 5.57e-08 | 6 | 50 | 3 | 15033447 | |
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 9.75e-08 | 7 | 50 | 3 | 20843900 | |
| Pubmed | 9.75e-08 | 7 | 50 | 3 | 17021187 | ||
| Pubmed | 9.75e-08 | 7 | 50 | 3 | 35228700 | ||
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 36733270 | ||
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 3.33e-07 | 10 | 50 | 3 | 21789198 | |
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 20583128 | ||
| Pubmed | 4.58e-07 | 11 | 50 | 3 | 7713516 | ||
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 4.58e-07 | 11 | 50 | 3 | 38894703 | |
| Pubmed | Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. | 6.09e-07 | 12 | 50 | 3 | 2561974 | |
| Pubmed | 6.40e-07 | 347 | 50 | 7 | 17114649 | ||
| Pubmed | 1.01e-06 | 14 | 50 | 3 | 22768092 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15294044 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22763624 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 14766194 | ||
| Pubmed | Molecular and neuronal substrate for the selective attenuation of anxiety. | 2.03e-06 | 2 | 50 | 2 | 11021797 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 18085262 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24553732 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21073549 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23147414 | ||
| Pubmed | α2-containing GABAA receptors expressed in hippocampal region CA3 control fast network oscillations. | 2.03e-06 | 2 | 50 | 2 | 23109109 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22666188 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23744069 | ||
| Pubmed | Functional mapping of GABA A receptor subtypes in the amygdala. | 2.03e-06 | 2 | 50 | 2 | 15341600 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8391122 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21056629 | ||
| Pubmed | GABRA1 and GABRA6 gene mutations in idiopathic generalized epilepsy patients. | 2.03e-06 | 2 | 50 | 2 | 34740144 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 10693762 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 18973555 | ||
| Pubmed | GABAA receptor alpha1 and alpha6 subunits mediate cell surface anchoring in cultured cells. | 2.03e-06 | 2 | 50 | 2 | 15196679 | |
| Pubmed | Reversal of pathological pain through specific spinal GABAA receptor subtypes. | 2.03e-06 | 2 | 50 | 2 | 18202657 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23067879 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 9655866 | ||
| Pubmed | Enrichment of GABAA Receptor α-Subunits on the Axonal Initial Segment Shows Regional Differences. | 2.03e-06 | 2 | 50 | 2 | 26973458 | |
| Pubmed | Localization of three genes expressed in retina on mouse chromosome 11. | 2.25e-06 | 18 | 50 | 3 | 7767000 | |
| Pubmed | 2.25e-06 | 18 | 50 | 3 | 18985723 | ||
| Pubmed | 4.53e-06 | 300 | 50 | 6 | 19086053 | ||
| Pubmed | 5.79e-06 | 81 | 50 | 4 | 22723691 | ||
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 6.07e-06 | 3 | 50 | 2 | 9060999 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 10819240 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 18063661 | ||
| Pubmed | GABRG1 and GABRA2 as independent predictors for alcoholism in two populations. | 6.07e-06 | 3 | 50 | 2 | 18818659 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 27128218 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 20844140 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 1359369 | ||
| Pubmed | Neurobeachin Regulates Glutamate- and GABA-Receptor Targeting to Synapses via Distinct Pathways. | 6.07e-06 | 3 | 50 | 2 | 25934101 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 15158081 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 10882481 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 11325525 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 29023704 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 15254090 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 29673739 | ||
| Pubmed | Candidate genes for alcohol dependence: A genetic association study from India. | 6.07e-06 | 3 | 50 | 2 | 28361821 | |
| Pubmed | The cDNA sequence and chromosomal location of the murine GABAA alpha 1 receptor gene. | 6.07e-06 | 3 | 50 | 2 | 1848528 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 16778401 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 34433078 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 32376074 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 9882483 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 6.50e-06 | 182 | 50 | 5 | 20468064 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 11902122 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 7829087 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 9105679 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 27244486 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 36277219 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 12232773 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 10381553 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 16176386 | ||
| Pubmed | Identification of multiple genetic loci linked to the propensity for "behavioral despair" in mice. | 1.21e-05 | 4 | 50 | 2 | 11875023 | |
| Pubmed | The genetics of alcohol dependence and alcohol-related liver disease. | 1.21e-05 | 4 | 50 | 2 | 27575312 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 14715953 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 1.21e-05 | 4 | 50 | 2 | 17367784 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 17440936 | ||
| Pubmed | Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. | 1.21e-05 | 4 | 50 | 2 | 20692323 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 11889801 | ||
| Pubmed | Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. | 1.21e-05 | 4 | 50 | 2 | 29562231 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 11160423 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 11013247 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 1533386 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 7643102 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 18218981 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 21209221 | ||
| Cytoband | 5q34 | 5.42e-04 | 32 | 49 | 2 | 5q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q34 | 8.91e-04 | 41 | 49 | 2 | chr5q34 | |
| Cytoband | 2p11.2 | 2.16e-03 | 64 | 49 | 2 | 2p11.2 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.96e-08 | 19 | 34 | 4 | 563 | |
| GeneFamily | Taste 2 receptors | 2.44e-03 | 39 | 34 | 2 | 1162 | |
| GeneFamily | Endogenous ligands|Interleukins | 2.95e-03 | 43 | 34 | 2 | 601 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 1.32e-05 | 166 | 48 | 5 | M2398 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 2.52e-05 | 190 | 48 | 5 | MM1311 | |
| Coexpression | GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN | 3.08e-05 | 198 | 48 | 5 | M7265 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN | 3.23e-05 | 200 | 48 | 5 | M6261 | |
| CoexpressionAtlas | Myeloid Cells, GN.BM, CD11b+ Ly6-G+, Bone marrow, avg-4 | 2.13e-05 | 415 | 44 | 7 | GSM605846_500 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.20e-06 | 192 | 49 | 5 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 1.71e-05 | 140 | 49 | 4 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 146 | 49 | 4 | 281144e293e8c93a425c2606d2188cb2838e667f | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.54e-05 | 155 | 49 | 4 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 157 | 49 | 4 | b527e88382c8d21188a0f222b3302523e8816dfc | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 159 | 49 | 4 | 323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 160 | 49 | 4 | a494001b1f6dec33624f98fa3c24bad6988d0425 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 175 | 49 | 4 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.18e-05 | 176 | 49 | 4 | da5933eb253f13e70296a50a2bb00ad5c19a2d99 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 186 | 49 | 4 | d72cdbb6d79ab33a5823c42e93c2ba566244f64c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 49 | 4 | fa71f9220b288ed6a1d06f347fec42649aac1f13 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 49 | 4 | f2a0d0829dc88aa93bfb2eebbbc0ef156a9cba84 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.51e-05 | 189 | 49 | 4 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 189 | 49 | 4 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.74e-05 | 191 | 49 | 4 | 1cd4d513ac363fdda07030b85a88174d29af3588 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 191 | 49 | 4 | 7411b253b16e4d472be0925dee49188f0fd6b0b5 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.98e-05 | 193 | 49 | 4 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.35e-05 | 196 | 49 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 198 | 49 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 198 | 49 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 198 | 49 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 198 | 49 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.73e-05 | 199 | 49 | 4 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.86e-05 | 200 | 49 | 4 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.86e-05 | 200 | 49 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| Computational | Genes in the cancer module 396. | 2.72e-06 | 12 | 26 | 3 | MODULE_396 | |
| Computational | Genes in the cancer module 141. | 6.89e-06 | 16 | 26 | 3 | MODULE_141 | |
| Computational | Neighborhood of RAP1A | 3.30e-04 | 140 | 26 | 4 | MORF_RAP1A | |
| Computational | Neurotransmitter (GABA) receptor. | 5.79e-04 | 15 | 26 | 2 | MODULE_215 | |
| Computational | Ion channels. | 6.18e-04 | 70 | 26 | 3 | MODULE_316 | |
| Drug | Meprobamate | 2.60e-10 | 6 | 48 | 4 | DB00371 | |
| Drug | Ethchlorvynol | 2.17e-09 | 9 | 48 | 4 | DB00189 | |
| Drug | Secobarbital | 3.62e-09 | 10 | 48 | 4 | DB00418 | |
| Drug | Chlordiazepoxide | 3.62e-09 | 10 | 48 | 4 | DB00475 | |
| Drug | Metharbital | 3.62e-09 | 10 | 48 | 4 | DB00463 | |
| Drug | Pentobarbital | 3.62e-09 | 10 | 48 | 4 | DB00312 | |
| Drug | Talbutal | 3.62e-09 | 10 | 48 | 4 | DB00306 | |
| Drug | Clobazam | 3.62e-09 | 10 | 48 | 4 | DB00349 | |
| Drug | Butalbital | 3.62e-09 | 10 | 48 | 4 | DB00241 | |
| Drug | Butabarbital | 3.62e-09 | 10 | 48 | 4 | DB00237 | |
| Drug | Bromazepam | 3.62e-09 | 10 | 48 | 4 | DB01558 | |
| Drug | Barbituric acid derivative | 3.62e-09 | 10 | 48 | 4 | DB01496 | |
| Drug | Barbital | 3.62e-09 | 10 | 48 | 4 | DB01483 | |
| Drug | Hexobarbital | 3.62e-09 | 10 | 48 | 4 | DB01355 | |
| Drug | Aprobarbital | 3.62e-09 | 10 | 48 | 4 | DB01352 | |
| Drug | Amobarbital | 3.62e-09 | 10 | 48 | 4 | DB01351 | |
| Drug | Heptabarbital | 3.62e-09 | 10 | 48 | 4 | DB01354 | |
| Drug | Butethal | 3.62e-09 | 10 | 48 | 4 | DB01353 | |
| Drug | Methylphenobarbital | 3.62e-09 | 10 | 48 | 4 | DB00849 | |
| Drug | Oxazepam | 3.62e-09 | 10 | 48 | 4 | DB00842 | |
| Drug | Primidone | 3.62e-09 | 10 | 48 | 4 | DB00794 | |
| Drug | Midazolam | 3.62e-09 | 10 | 48 | 4 | DB00683 | |
| Drug | Flurazepam | 3.62e-09 | 10 | 48 | 4 | DB00690 | |
| Drug | Thiopental | 5.67e-09 | 11 | 48 | 4 | DB00599 | |
| Drug | Alprazolam | 5.67e-09 | 11 | 48 | 4 | DB00404 | |
| Drug | Temazepam | 5.67e-09 | 11 | 48 | 4 | DB00231 | |
| Drug | Nitrazepam | 5.67e-09 | 11 | 48 | 4 | DB01595 | |
| Drug | Lorazepam | 5.67e-09 | 11 | 48 | 4 | DB00186 | |
| Drug | Phenobarbital | 5.67e-09 | 11 | 48 | 4 | DB01174 | |
| Drug | Triazolam | 5.67e-09 | 11 | 48 | 4 | DB00897 | |
| Drug | Clorazepate | 5.67e-09 | 11 | 48 | 4 | DB00628 | |
| Drug | Zolpidem | 8.79e-09 | 3 | 48 | 3 | DB00425 | |
| Drug | Flumazenil | 3.51e-08 | 4 | 48 | 3 | DB01205 | |
| Drug | dihydroxyaflavinine | 4.05e-08 | 17 | 48 | 4 | CID000156857 | |
| Drug | thymol | 4.32e-08 | 46 | 48 | 5 | CID000006989 | |
| Drug | Eszopiclone | 8.77e-08 | 5 | 48 | 3 | DB00402 | |
| Drug | Zopiclone | 8.77e-08 | 5 | 48 | 3 | DB01198 | |
| Drug | Lorazepam | 8.77e-08 | 5 | 48 | 3 | ctd:D008140 | |
| Drug | endrine | 9.24e-08 | 106 | 48 | 6 | CID000003048 | |
| Drug | Flunitrazepam | 1.75e-07 | 6 | 48 | 3 | DB01544 | |
| Drug | methohexital | 1.79e-07 | 24 | 48 | 4 | CID000009034 | |
| Drug | picrotoxinine | 2.52e-07 | 65 | 48 | 5 | CID000004816 | |
| Drug | trans-4-aminocrotonic acid | 2.94e-07 | 67 | 48 | 5 | CID000002766 | |
| Drug | Quazepam | 3.06e-07 | 7 | 48 | 3 | DB01589 | |
| Drug | etazolate | 3.97e-07 | 29 | 48 | 4 | CID000003277 | |
| Drug | 3-isothujone | 4.58e-07 | 30 | 48 | 4 | CID000011027 | |
| Drug | Adinazolam | 4.89e-07 | 8 | 48 | 3 | DB00546 | |
| Drug | Fludiazepam | 4.89e-07 | 8 | 48 | 3 | DB01567 | |
| Drug | Clotiazepam | 4.89e-07 | 8 | 48 | 3 | DB01559 | |
| Drug | Cinolazepam | 4.89e-07 | 8 | 48 | 3 | DB01594 | |
| Drug | Prazepam | 4.89e-07 | 8 | 48 | 3 | DB01588 | |
| Drug | Estazolam | 4.89e-07 | 8 | 48 | 3 | DB01215 | |
| Drug | Halazepam | 4.89e-07 | 8 | 48 | 3 | DB00801 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 4.89e-07 | 8 | 48 | 3 | ctd:C091518 | |
| Drug | CGS 8216 | 6.80e-07 | 33 | 48 | 4 | CID000104916 | |
| Drug | AC1L2FYN | 6.80e-07 | 33 | 48 | 4 | CID000071333 | |
| Drug | tiotidine | 7.32e-07 | 9 | 48 | 3 | ctd:C023990 | |
| Drug | Diazepam | 7.32e-07 | 9 | 48 | 3 | DB00829 | |
| Drug | flurazepam | 8.68e-07 | 35 | 48 | 4 | CID000003393 | |
| Drug | Clonazepam | 1.04e-06 | 10 | 48 | 3 | DB01068 | |
| Drug | AC1L1FKW | 1.04e-06 | 10 | 48 | 3 | CID000003281 | |
| Drug | secobarbital | 1.09e-06 | 37 | 48 | 4 | CID000005193 | |
| Drug | DMCM | 1.22e-06 | 38 | 48 | 4 | CID000104999 | |
| Drug | zaleplon | 1.35e-06 | 39 | 48 | 4 | CID000005719 | |
| Drug | fosazepam | 1.43e-06 | 11 | 48 | 3 | CID000037114 | |
| Drug | C19H18ClN3O | 1.43e-06 | 11 | 48 | 3 | CID000027452 | |
| Drug | flutoprazepam | 1.43e-06 | 11 | 48 | 3 | CID000003400 | |
| Drug | Arfendazam | 1.43e-06 | 11 | 48 | 3 | CID000065803 | |
| Drug | camazepam | 1.43e-06 | 11 | 48 | 3 | CID000037367 | |
| Drug | triflubazam | 1.43e-06 | 11 | 48 | 3 | CID000031157 | |
| Drug | Bu-1014 | 1.43e-06 | 11 | 48 | 3 | CID015942721 | |
| Drug | Zapizolam | 1.43e-06 | 11 | 48 | 3 | CID000068832 | |
| Drug | Reclazepam | 1.43e-06 | 11 | 48 | 3 | CID003052777 | |
| Drug | iclazepam | 1.43e-06 | 11 | 48 | 3 | CID000068777 | |
| Drug | menitrazepam | 1.43e-06 | 11 | 48 | 3 | CID000189875 | |
| Drug | Serin hydrazid | 1.43e-06 | 11 | 48 | 3 | CID000041637 | |
| Drug | sulazepam | 1.43e-06 | 11 | 48 | 3 | CID000017931 | |
| Drug | elfazepam | 1.43e-06 | 11 | 48 | 3 | CID000065445 | |
| Drug | uldazepam | 1.43e-06 | 11 | 48 | 3 | CID000034274 | |
| Drug | gidazepam | 1.43e-06 | 11 | 48 | 3 | CID000121919 | |
| Drug | fletazepam | 1.43e-06 | 11 | 48 | 3 | CID000036834 | |
| Drug | Gabrene | 1.50e-06 | 40 | 48 | 4 | CID005361323 | |
| Drug | gaboxadol | 1.66e-06 | 41 | 48 | 4 | CID000003448 | |
| Drug | 5 beta-alphaxalone | 1.83e-06 | 42 | 48 | 4 | CID000068930 | |
| Drug | SB-205384 | 1.91e-06 | 12 | 48 | 3 | CID000197690 | |
| Drug | U-93631 | 1.91e-06 | 12 | 48 | 3 | CID000197626 | |
| Drug | haloxazolam | 1.91e-06 | 12 | 48 | 3 | CID000003563 | |
| Drug | pivoxazepam | 1.91e-06 | 12 | 48 | 3 | CID000068722 | |
| Drug | doxefazepam | 1.91e-06 | 12 | 48 | 3 | CID000038668 | |
| Drug | razobazam | 1.91e-06 | 12 | 48 | 3 | CID000071228 | |
| Drug | zolpidem | 2.02e-06 | 43 | 48 | 4 | CID000005732 | |
| Drug | L-quisqualic acid | 2.09e-06 | 180 | 48 | 6 | CID000001209 | |
| Drug | lorazepam | 2.22e-06 | 44 | 48 | 4 | CID000003958 | |
| Drug | AC1MVFYM | 2.48e-06 | 13 | 48 | 3 | CID003707225 | |
| Drug | nerisopam | 2.48e-06 | 13 | 48 | 3 | CID000065875 | |
| Drug | Ro 11-3128 | 2.48e-06 | 13 | 48 | 3 | CID000093364 | |
| Drug | cinolazepam | 2.48e-06 | 13 | 48 | 3 | CID003033621 | |
| Drug | flutazolam | 2.48e-06 | 13 | 48 | 3 | CID000003398 | |
| Drug | alpha IMGBL | 2.48e-06 | 13 | 48 | 3 | CID000131516 | |
| Drug | 4-PIOL | 2.48e-06 | 13 | 48 | 3 | CID000125520 | |
| Disease | Cannabis Dependence | 3.19e-04 | 17 | 46 | 2 | C0006870 | |
| Disease | Glioma | 3.43e-04 | 87 | 46 | 3 | C0017638 | |
| Disease | Autistic Disorder | 7.29e-04 | 261 | 46 | 4 | C0004352 | |
| Disease | Alcoholic Intoxication, Chronic | 8.05e-04 | 268 | 46 | 4 | C0001973 | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.14e-03 | 32 | 46 | 2 | DOID:10273 (implicated_via_orthology) | |
| Disease | diverticulitis | 1.53e-03 | 37 | 46 | 2 | EFO_1001460 | |
| Disease | autistic disorder (is_implicated_in) | 1.97e-03 | 42 | 46 | 2 | DOID:12849 (is_implicated_in) | |
| Disease | Schizophrenia | 2.38e-03 | 883 | 46 | 6 | C0036341 | |
| Disease | Tourette syndrome | 2.78e-03 | 50 | 46 | 2 | EFO_0004895 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVCNRHSFRQDSMWV | 196 | O43306 | |
| MFGWTHVTLLIVVTQ | 196 | O95674 | |
| CWQVMNVATILATFV | 441 | P13056 | |
| WNSLSTCHIRMVISA | 151 | Q8N682 | |
| CLMVFKNHWSQVVRI | 36 | Q8N612 | |
| VMNHKVCIQLIIASW | 126 | Q8NH19 | |
| HVVWSLFNTLFMNTC | 56 | Q01629 | |
| IITFWQVMLRNTTCH | 316 | O75752 | |
| CIMTVILSQVSFWLN | 261 | P47869 | |
| LQWVTSQVFTRVLMC | 386 | Q9NST1 | |
| RWNCLVARQHIEMST | 336 | P27487 | |
| CIMTVILSQVSFWLN | 286 | P34903 | |
| CIMTVILSQVSFWLN | 261 | P14867 | |
| CIMTVILSQVSFWIN | 251 | Q16445 | |
| TLIRQNWVMTAAHCV | 51 | Q9UNI1 | |
| MCHQQLVISWFSLVF | 1 | P29460 | |
| VWQEHCSSIVMITKL | 976 | Q92729 | |
| HQMVNNICQFIFWTV | 206 | Q9BPV8 | |
| HPSQVILTVSQIMWC | 1316 | Q9C0G6 | |
| SWVNCSNMIDEIITH | 31 | P08700 | |
| TWLCSQAHTSMVLQL | 271 | Q9BQN1 | |
| VMSRVFLIWAVTHSV | 111 | Q6Y1H2 | |
| QHITIHCLNMTVWQE | 1761 | Q8IZC6 | |
| MLAQWCTQAHSLTLQ | 606 | Q8TF61 | |
| DLRIHVSCRMLQNTW | 2211 | Q9UGM3 | |
| IVEWITHQFCAMALT | 221 | Q6T423 | |
| MHDLLLWNNATVTTC | 181 | P11586 | |
| WVCQRSTVASMMHRQ | 271 | Q13555 | |
| ACHLFVVNMNQIVWT | 141 | P59539 | |
| VCHLFVINMNQIIWT | 141 | P59540 | |
| QVSEHTQLSWILSCM | 116 | Q9UGM6 | |
| WVCQRSTVASMMHRQ | 271 | Q13554 | |
| CVHSRTQAVGMWQVL | 251 | Q8WZA2 | |
| QTQEQMSRDVCIHTW | 41 | Q5SQN1 | |
| NNWTEECTHLVMVSV | 141 | O60934 | |
| QTAWIHSIVDCVTML | 86 | Q6ZSM3 | |
| IRQVLHNLSMWCARS | 811 | P35251 | |
| QVLKVCANHWITTTM | 1096 | P0DJD1 | |
| NMLCISVNSHIYQRW | 576 | Q8IVG5 | |
| TCQAEIWSMFTAILR | 131 | Q8NFP9 | |
| QMLVYREQHRSWCTL | 726 | Q9BVR0 | |
| MNRHTCNFVVLVSWV | 136 | Q8NGU2 | |
| MQVTFCRLRTHQWCF | 1 | A8MXE2 | |
| IITWNELCHVAETMS | 281 | Q13705 | |
| SQWALVVQFCRLHNM | 1341 | Q96JI7 | |
| LRNIMCSYIWQHIEI | 961 | Q2NKQ1 | |
| MFSSIVCSVPHTWQQ | 401 | Q9C0H2 | |
| NFLTVGSVLQMWHIV | 126 | O15209 | |
| FLRNVTWVMVNLCRH | 216 | O00629 | |
| RMHAWNSICSTLVTN | 711 | Q86W25 |